ÃÑ 300ÆäÀÌÁö
3ÆäÀÌÁö º»¹®½ÃÀÛ
1. ÃֽŠÇÁ¸®¿Â Áø´Ü¹ý ¹× ¿¬±¸µ¿Ç⡤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 1
ÇѾç´ëÇб³ ¾àÇдëÇÐ ·ùÁ¾¼® ±³¼ö
2. Sampling and detection of waterborne virus in envrionment¡¤¡¤¡¤¡¤¡¤¡¤37
Áß¾Ó´ëÇб³ ½ÄÇ°¿µ¾çÇаú ÃÖâ¼ø ±³¼ö
3. Áúº´¸ð´ÏÅ͸µÀ» À§ÇÑ Ç¥º»Á¶»çÀÇ Åë°èÀû ¹æ¹ý¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 57
Ä«À̽ºÆ® Á¤¿¬½Â ±³¼ö
4. »ý¹°¾ÈÀü 3µî±Þ ¿¬±¸½Ã¼³ ÀÌ¿ëÀÚ ±³À°¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 75
¢ßºñ¿¡½º·¦ ÀüÅ¿ø ´ëÇ¥
5. LNA(Locked nucleic acid) ¿ø¸® ¹× È°¿ë »ç·Ê¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 101
Äû¾ÆÁ¨ ÄÚ¸®¾Æ ³ë¹ÌÈñ °úÀå
6. ÇöÀå¿¡¼ º» ¾ÆÇÁ¸®Ä«µÅÁö¿º´¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 121
¢ßµµµå¶÷¾çµ·Á¶ÇÕ Á¤Çö±Ô ¿øÀå
7. Prion-like protein in neurodegenerative disease¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 163
Çѱ¹³ú¿¬±¸¿ø ½ÇÇ赿¹°¿î¿µ¼¾ÅÍ ÃÖ¿µÇ¥ ½ÇÀå
8. NGS ±â¹Ý Target-Seq °³¿ä ¹× È°¿ë¹æ¹ý¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 189
¢ß¼¿·¹¹Í½º ÀåÈÆ ¹Ú»ç
9. CRISPR/Cas9À» ÀÌ¿ëÇÑ Virus gene editing¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 203
¢ßÅøÁ¨ ±¸¿ÁÁ¦ ÀÌ»ç
10. °¨¿°¼ºÁúº´ÀÇ ´Ü¹éÁú ±¸Á¶ºÐ¼®°ú ÀçÁ¶ÇÕ ±â¹ýÀ» È°¿ëÇÑ ¿¹¹æ¿¬±¸¡¤¡¤¡¤¡¤223
¿¬¼¼´ëÇб³ »ý¸í°úÇбâ¼úºÎ È«¹Î¼± ±³¼ö
11. ÀΰøÁö´ÉÀÇ °ú°Å¿Í ÇöÀç, ±×¸®°í ´Ù°¡¿Ã ¼¼»óÀº...
µ¿¹°Àü¿°º´ÀÇ ¿¹¹æ±îÁö¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
251
¼¿ï´ëÇб³ ¼öÀÇ°ú´ëÇÐ ÅÂÁÖÈ£ ±³¼ö
12. ÁßÁõ¿¼ºÇ÷¼ÒÆÇ°¨¼ÒÁõÈıº ¸¶¿ì½º¸ðµ¨ ±¸Ãà ¹× º´¿ø¼º ¿¬±¸¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤265
ÀüºÏ´ëÇб³ ¼öÀÇ°ú´ëÇÐ ±è¹ü¼® ±³¼ö
ÇѾç´ëÇб³ ¾àÇдëÇÐ ·ùÁ¾¼® ±³¼ö
2. Sampling and detection of waterborne virus in envrionment¡¤¡¤¡¤¡¤¡¤¡¤37
Áß¾Ó´ëÇб³ ½ÄÇ°¿µ¾çÇаú ÃÖâ¼ø ±³¼ö
3. Áúº´¸ð´ÏÅ͸µÀ» À§ÇÑ Ç¥º»Á¶»çÀÇ Åë°èÀû ¹æ¹ý¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 57
Ä«À̽ºÆ® Á¤¿¬½Â ±³¼ö
4. »ý¹°¾ÈÀü 3µî±Þ ¿¬±¸½Ã¼³ ÀÌ¿ëÀÚ ±³À°¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 75
¢ßºñ¿¡½º·¦ ÀüÅ¿ø ´ëÇ¥
5. LNA(Locked nucleic acid) ¿ø¸® ¹× È°¿ë »ç·Ê¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 101
Äû¾ÆÁ¨ ÄÚ¸®¾Æ ³ë¹ÌÈñ °úÀå
6. ÇöÀå¿¡¼ º» ¾ÆÇÁ¸®Ä«µÅÁö¿º´¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 121
¢ßµµµå¶÷¾çµ·Á¶ÇÕ Á¤Çö±Ô ¿øÀå
7. Prion-like protein in neurodegenerative disease¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 163
Çѱ¹³ú¿¬±¸¿ø ½ÇÇ赿¹°¿î¿µ¼¾ÅÍ ÃÖ¿µÇ¥ ½ÇÀå
8. NGS ±â¹Ý Target-Seq °³¿ä ¹× È°¿ë¹æ¹ý¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 189
¢ß¼¿·¹¹Í½º ÀåÈÆ ¹Ú»ç
9. CRISPR/Cas9À» ÀÌ¿ëÇÑ Virus gene editing¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤ 203
¢ßÅøÁ¨ ±¸¿ÁÁ¦ ÀÌ»ç
10. °¨¿°¼ºÁúº´ÀÇ ´Ü¹éÁú ±¸Á¶ºÐ¼®°ú ÀçÁ¶ÇÕ ±â¹ýÀ» È°¿ëÇÑ ¿¹¹æ¿¬±¸¡¤¡¤¡¤¡¤223
¿¬¼¼´ëÇб³ »ý¸í°úÇбâ¼úºÎ È«¹Î¼± ±³¼ö
11. ÀΰøÁö´ÉÀÇ °ú°Å¿Í ÇöÀç, ±×¸®°í ´Ù°¡¿Ã ¼¼»óÀº...
µ¿¹°Àü¿°º´ÀÇ ¿¹¹æ±îÁö¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
251
¼¿ï´ëÇб³ ¼öÀÇ°ú´ëÇÐ ÅÂÁÖÈ£ ±³¼ö
12. ÁßÁõ¿¼ºÇ÷¼ÒÆÇ°¨¼ÒÁõÈıº ¸¶¿ì½º¸ðµ¨ ±¸Ãà ¹× º´¿ø¼º ¿¬±¸¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤265
ÀüºÏ´ëÇб³ ¼öÀÇ°ú´ëÇÐ ±è¹ü¼® ±³¼ö
3ÆäÀÌÁö º»¹®³¡
¸Þ´º
ÇöÀç Æ÷Ä¿½ºÀÇ ¾Æ·¡³»¿ëµéÀº µ¿ÀÏÇÑ ÄÁÅÙÃ÷¸¦ °¡Áö°í ÆäÀÌÁö³Ñ±è È¿°ú¹× ½Ã°¢Àû È¿°ú¸¦ Á¦°øÇÏ´Â ÆäÀÌÁöÀ̹ǷΠ½ºÅ©¸°¸®´õ »ç¿ëÀÚ´Â ¿©±â±îÁö¸¸ ³¶µ¶ÇϽðí À§ÀÇ ÆäÀÌÁöÀ̵¿ ¸µÅ©¸¦ »ç¿ëÇÏ¿© ´ÙÀ½ÆäÀÌÁö·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.